Zhejiang Jiuzhou Pharmaceutical Co., Ltd (SHA:603456)
14.47
+0.08 (0.56%)
Apr 2, 2025, 2:45 PM CST
SHA:603456 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Net Income | 697.36 | 1,033 | 921.17 | 633.9 | 380.58 | 237.79 | Upgrade
|
Depreciation & Amortization | 375.21 | 375.21 | 348.2 | 292.08 | 252.31 | 190.93 | Upgrade
|
Other Amortization | 8.46 | 8.46 | 1.76 | 0.26 | 0.48 | 1.61 | Upgrade
|
Loss (Gain) From Sale of Assets | 2.54 | 2.54 | 4.79 | 7.99 | 3.03 | 0.12 | Upgrade
|
Asset Writedown & Restructuring Costs | 2.61 | 2.61 | 4.94 | 24.99 | 5.34 | 11.45 | Upgrade
|
Loss (Gain) From Sale of Investments | 19.36 | 19.36 | 23.99 | -59.81 | -32.44 | 23.01 | Upgrade
|
Provision & Write-off of Bad Debts | 19.38 | 19.38 | -5.71 | 7.56 | 6.46 | -5.58 | Upgrade
|
Other Operating Activities | -68.41 | 86.93 | -7.29 | 78.53 | 103.38 | 3.13 | Upgrade
|
Change in Accounts Receivable | -228.54 | -228.54 | 84.29 | -312.34 | -185.57 | 38.81 | Upgrade
|
Change in Inventory | -9.39 | -9.39 | -386.67 | -510.21 | -364.55 | -20.74 | Upgrade
|
Change in Accounts Payable | 14.46 | 14.46 | 194.44 | 492.07 | 205.45 | 57.71 | Upgrade
|
Change in Other Net Operating Assets | 17.15 | 17.15 | 34.81 | -0.47 | - | - | Upgrade
|
Operating Cash Flow | 869.08 | 1,360 | 1,226 | 677.52 | 400.39 | 554.16 | Upgrade
|
Operating Cash Flow Growth | -23.41% | 10.98% | 80.92% | 69.21% | -27.75% | 109.29% | Upgrade
|
Capital Expenditures | -1,061 | -929.44 | -713.79 | -579.88 | -315.73 | -320.45 | Upgrade
|
Sale of Property, Plant & Equipment | 3.94 | 4 | 8.55 | 8.25 | 43.02 | 7.29 | Upgrade
|
Cash Acquisitions | -6.5 | -113.34 | -31.28 | 34.67 | - | -64.9 | Upgrade
|
Investment in Securities | -12.07 | -41.27 | -6.79 | -279.99 | -10.83 | 10.17 | Upgrade
|
Other Investing Activities | 23.29 | 23.25 | 4.89 | 60.53 | 73 | -293.83 | Upgrade
|
Investing Cash Flow | -1,053 | -1,057 | -738.42 | -765.44 | -210.53 | -661.72 | Upgrade
|
Long-Term Debt Issued | - | 2,113 | 923.89 | 1,446 | 1,833 | 1,714 | Upgrade
|
Total Debt Issued | 2,077 | 2,113 | 923.89 | 1,446 | 1,833 | 1,714 | Upgrade
|
Long-Term Debt Repaid | - | -2,059 | -1,290 | -1,686 | -1,768 | -1,432 | Upgrade
|
Total Debt Repaid | -2,590 | -2,059 | -1,290 | -1,686 | -1,768 | -1,432 | Upgrade
|
Net Debt Issued (Repaid) | -513.15 | 53.36 | -366.21 | -239.54 | 65.47 | 281.71 | Upgrade
|
Issuance of Common Stock | - | 2,491 | 42.23 | 1,020 | 30.66 | - | Upgrade
|
Repurchase of Common Stock | -1.25 | -1.25 | -1.73 | -1.29 | -9.39 | - | Upgrade
|
Common Dividends Paid | -468.41 | -386.09 | -234.88 | -190.63 | -202.86 | -169.96 | Upgrade
|
Other Financing Activities | -104.66 | -54.84 | -48.38 | -6.01 | - | -0.53 | Upgrade
|
Financing Cash Flow | -1,087 | 2,102 | -608.96 | 582.43 | -116.12 | 111.22 | Upgrade
|
Foreign Exchange Rate Adjustments | -20.76 | 7.6 | 57.61 | -22.59 | -51.49 | -3.86 | Upgrade
|
Net Cash Flow | -1,292 | 2,413 | -63.99 | 471.92 | 22.25 | -0.2 | Upgrade
|
Free Cash Flow | -192.16 | 430.88 | 511.99 | 97.64 | 84.67 | 233.71 | Upgrade
|
Free Cash Flow Growth | - | -15.84% | 424.38% | 15.32% | -63.77% | 584.94% | Upgrade
|
Free Cash Flow Margin | -3.91% | 7.80% | 9.40% | 2.40% | 3.20% | 11.59% | Upgrade
|
Free Cash Flow Per Share | -0.21 | 0.48 | 0.62 | 0.12 | 0.10 | 0.29 | Upgrade
|
Cash Income Tax Paid | - | -27.32 | -51.28 | -126.44 | -105.97 | -0.06 | Upgrade
|
Levered Free Cash Flow | -546.69 | -376.18 | 397.76 | 238.83 | -257.43 | 174.83 | Upgrade
|
Unlevered Free Cash Flow | -534.24 | -362.6 | 411.74 | 254.37 | -230.21 | 181.06 | Upgrade
|
Change in Net Working Capital | 332.13 | 525.17 | -99.45 | -68.18 | 466.03 | -130.51 | Upgrade
|
Updated Oct 24, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.